INTERNATIONAL BIOTECHNOLOGY TRUST PLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,193,620
-10.1%
74,000
+131.2%
0.40%
-0.5%
Q2 2023$1,327,680
-31.0%
32,0000.0%0.40%
-24.8%
Q1 2023$1,924,480
-17.9%
32,0000.0%0.54%
-25.8%
Q4 2022$2,344,000
-3.6%
32,0000.0%0.72%
-7.2%
Q3 2022$2,431,000
-92.4%
32,000
+1338.8%
0.78%
+133.5%
Q2 2022$32,000,000
+969.9%
2,224
-93.7%
0.33%
-69.0%
Q4 2019$2,991,00035,5001.08%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders